134 related articles for article (PubMed ID: 29593651)
21. Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions.
Shimo N; Matsuoka TA; Miyatsuka T; Takebe S; Tochino Y; Takahara M; Kaneto H; Shimomura I
Biochem Biophys Res Commun; 2015 Nov; 467(4):948-54. PubMed ID: 26471305
[TBL] [Abstract][Full Text] [Related]
22. Exendin-4 protects hypoxic islets from oxidative stress and improves islet transplantation outcome.
Padmasekar M; Lingwal N; Samikannu B; Chen C; Sauer H; Linn T
Endocrinology; 2013 Apr; 154(4):1424-33. PubMed ID: 23471218
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
[TBL] [Abstract][Full Text] [Related]
24. Endogenous GLP-1 as a key self-defense molecule against lipotoxicity in pancreatic islets.
Huang C; Yuan L; Cao S
Int J Mol Med; 2015 Jul; 36(1):173-85. PubMed ID: 25976560
[TBL] [Abstract][Full Text] [Related]
25. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
Lampropoulou E; Lymperopoulou A; Charonis A
Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
[TBL] [Abstract][Full Text] [Related]
26. Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats.
Laybutt DR; Hawkins YC; Lock J; Lebet J; Sharma A; Bonner-Weir S; Weir GC
Diabetologia; 2007 Oct; 50(10):2117-25. PubMed ID: 17641871
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
Wang Q; Brubaker PL
Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
Ladefoged M; Buschard K; Hansen AM
APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
[TBL] [Abstract][Full Text] [Related]
29. Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 Diabetes.
Brissova M; Shostak A; Fligner CL; Revetta FL; Washington MK; Powers AC; Hull RL
J Histochem Cytochem; 2015 Aug; 63(8):637-45. PubMed ID: 26216139
[TBL] [Abstract][Full Text] [Related]
30. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
Piercy V; Toseland CD; Turner NC
Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of oleanolic acid against beta cell dysfunction and mitochondrial apoptosis: crucial role of ERK-NRF2 signaling pathway.
Wang X; Chen HL; Liu JZ; Liao N; Yu WH; Zhang XD; Zhang T; Li WL; Hai CX
J Biol Regul Homeost Agents; 2013; 27(1):55-67. PubMed ID: 23489687
[TBL] [Abstract][Full Text] [Related]
32. Glucose potentiates β-cell function by inducing
Zhang Y; Deng R; Yang X; Xu W; Liu Y; Li F; Zhang J; Tang H; Ji X; Bi Y; Wang X; Zhou L; Ning G
FASEB J; 2017 Dec; 31(12):5342-5355. PubMed ID: 28794173
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA Sequences Modulated by Beta Cell Lipid Metabolism: Implications for Type 2 Diabetes Mellitus.
Tarlton JMR; Patterson S; Graham A
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34203703
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia Affects the Antioxidant Activity of Glutaredoxin 3 in
Jie YK; Cheng CH; Ma HL; Liu GX; Fan SG; Jiang JJ; Guo ZX
Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670937
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological blockade of the EP3 prostaglandin E
Bosma KJ; Andrei SR; Katz LS; Smith AA; Dunn JC; Ricciardi VF; Ramirez MA; Baumel-Alterzon S; Pace WA; Carroll DT; Overway EM; Wolf EM; Kimple ME; Sheng Q; Scott DK; Breyer RM; Gannon M
Mol Metab; 2021 Dec; 54():101347. PubMed ID: 34626853
[TBL] [Abstract][Full Text] [Related]
36. Lipotoxic Impairment of Mitochondrial Function in β-Cells: A Review.
Römer A; Linn T; Petry SF
Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672062
[TBL] [Abstract][Full Text] [Related]
37. Distinct Shift in Beta-Cell Glutaredoxin 5 Expression Is Mediated by Hypoxia and Lipotoxicity Both
Petry SF; Sun LM; Knapp A; Reinl S; Linn T
Front Endocrinol (Lausanne); 2018; 9():84. PubMed ID: 29593651
[TBL] [Abstract][Full Text] [Related]
38. Loss and Recovery of Glutaredoxin 5 Is Inducible by Diet in a Murine Model of Diabesity and Mediated by Free Fatty Acids In Vitro.
Petry SF; Römer A; Rawat D; Brunner L; Lerch N; Zhou M; Grewal R; Sharifpanah F; Sauer H; Eckert GP; Linn T
Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453472
[TBL] [Abstract][Full Text] [Related]
39. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
Garris DR; Garris BL
Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]